Background This multi-center, phase III trial assesses the efficacy of daikenchuto (TU-100) on gastrointestinal disorders after hepatic resection (UMIN Registration No. 000003103). Materials and methods A total of 231 patients, who underwent hepatic resection at 26 Japanese centers, were enrolled. …